Abstract
Sand rats were used as a model for nutritionally induced type II (non-insulin-dependent) diabetes in an effort to evaluate the effect of acarbose on carbohydrate digestion. Daily plasma glucose profiles, insulin levels and weekly cararact development were determined following long-term feeding with a diet containing acarbose (20 or 40 mg/100 g diet). Acarbose not only dramatically decreased daily plasma glucose and insulin levels (p<0.05) but also delayed, and possibly prevented, cataract formation in sand rats. The effect of acarbose persisted for 150 days. The control of daily plasma glucose levels and reduction of insulin levels obtained with acarbose may lead to the delay of cataract formation in sand rats. These results could have potential applications to diabetic patients as an adjunct treatment.
Similar content being viewed by others
Article PDF
References
Kotovich MJ, Meldrum MJ, Vasselli JR . Beneficial effects of dietary acarbose in the streptozotocin-induced diabetic rat. Metabolism 1991; 40: 1275–82.
Madar Z . The effect of acarbose and BAY M 1099 on postprandial glucose levels following ingestion of various sources of starch in non-diabetic and diabetic rats. J Nutr 1989; 11: 2023–9.
Clissold SP, Edwards C . Acarbose: a preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 1988; 35: 214–43.
Sachse G, Willms B . Effect of the alpha-glucosidase inhibitor BAY-G-5421 on blood glucose control of sulfonylurea-treated diabetics and insulin-treated diabetics. Diabetologia 1979; 17: 287–90.
Shafrir E . Diabetes in animals. In: Rifkin H, Purte D, editors. Diabetes mellitus: theory and practice. 4th ed. New York: Elsevier, 1990:322–4.
Adler JH, Lazarovich GO, Marton M, Levy E . The diabetic response of weanling sand rat (Psammomys obesus) to diet containing different concentrations of salt (A triplex hali-mus). Diabetes Res 1986; 3: 169–71.
Marquie G, Duhault J, Jacotot B . Diabetes mellitus in sand rats (Psammomys obesus): metabolic pattern during development of the diabetic syndrome. Diabetes 1984; 33: 438–43.
Hackel OB, Mikat E, Lebovitz HE, Schmidt-Nielsen K, Horton ES, Kinney TD . The sand rat (Psammomys obesus) as an experimental animal in studies of diabetes mellitus. Diabetologia 1967; 3: 130–40.
Gutman A, Andrews A, Adler JH . Hyperinsulinemia, insulin resistance and cataract formation in sand rats. Isr J Med Sci 1975; 11: 714–22.
Van Heningen R . Formation of polyols by the lens of the rat with sugar cataract. Nature 1959; 184: 194–5.
Yoshioka S, Kameyama K, Sanaka M . Effect of diabetes on the free polyol pattern in cataractous lenses. Clin Chem 1991; 37: 686–9.
Bunce GE, Kinoshita J, Horwitz J . Nutritional factors in cataracts. Annu Rev Nutr 1990; 10: 233–54.
Desbuquiois B, Aurbach BA . Use of polyethyleneglycol to separate free and antibody bound peptide hormones by radioimmunoassay. J Clin Endocrinol Metab 1972; 33: 373–8.
Hutton JC, Schofield PJ, Williams JF, Regtop HL, Hollows FC . The effect of an unsaturated fat diet on cataract formation in streptozotocin-induced diabetic rats. Br J Nutr 1976; 36: 161–77.
Akagi Y, Terubayashi H, Ikebe H, Mori K . Morphological classification of the prevention of aldose reductase inhibitor on rat galactosemic cataract. In: Sakamoto H, editor. Current concepts of aldose reductase and its inhibitors. New York: Elsevier, 1990:157–62.
Kalderon B, Gutman A, Levy E . Shfrir E, Adler JH . Characterisation of stages in development of obesity: diabetes syndrome in sand rat (Psammomys obesus). Diabetes 1986; 35: 717–24.
Kador PF, Akagi Y, Kinoshita JH . The effect of aldose reductase and its inhibition on sugar cataract formation. Metabolism 1986; 35 (Suppl 1): 15–9.
Crabe MJ, James M . Aldose reductase inhibitors and cataract. Int Ophthalmol 1991; 15: 25–36.
Author information
Authors and Affiliations
Rights and permissions
About this article
This article is cited by
-
Four anti-aging drugs and calorie-restricted diet produce parallel effects in fat, brain, muscle, macrophages, and plasma of young mice
GeroScience (2023)
-
Rapamycin, Acarbose and 17α-estradiol share common mechanisms regulating the MAPK pathways involved in intracellular signaling and inflammation
Immunity & Ageing (2022)